BioWisdom Limited

BioWisdom Limited

January 29, 2007 06:11 ET

BioWisdom and OmniViz combine to create a powerful new global force in Healthcare Intelligence

CAMBRIDGE, UNITED KINGDOM and MAYNARD, MASSACHUSETTS and COLUMBUS, OHIO--(CCNMatthews - Jan. 29, 2007) - BioWisdom Limited and OmniViz Inc announce that the two companies have combined to provide powerful technologies for the acquisition, integration, visualisation and high value analysis of healthcare information. The combined group will be a world leader in the provision of healthcare intelligence to the pharmaceutical industry.

OmniViz was a spin-out of Battelle's Pacific Northwest National Laboratory. As a result of the transaction, Battelle will become BioWisdom's third largest shareholder after MB Ventures and Merlin Biosciences.

"As a follow on to the acquisition of LION's bioinformatics business in April 2006 this transaction is an important part of our strategy of achieving growth by strong sales performance combined with selective mergers and acquisitions" said Gordon Baxter, BioWisdom CEO.

The OmniViz product, together with the Sofia and SRS products will now form an integral part of BioWisdom's Software business and also support BioWisdom's Content and Services businesses.

"The combination of technologies will enable customers to extract greater value from the overwhelming amounts of biomedical information, ultimately leading to improved healthcare," said Jeff Saffer, OmniViz President, now President of BioWisdom's US operations.

In addition to complementary technology, operational synergies provide BioWisdom with strong footprints in both North America and Europe, enabling better worldwide support of its customer base.


Notes to Editors

BioWisdom creates Intelligence Networks™ using its Sofia suite of tools and proprietary methodology. Intelligence Networks allow unbiased, systematic analysis of problems and are used to support decision-making in all areas of the healthcare industry. The company helps clients to navigate the complex scientific and commercial issues involved in developing successful healthcare products. The BioWisdom team combines extensive experience of the pharmaceutical and biotechnology industries with proven expertise in life science software development.

For further information, please visit

OmniViz Inc. provides unique, advanced visual informatics software, components, and services that radically enhance productivity and effectiveness. OmniViz solutions, designed to deal with very large data sets (e.g., hundreds to millions of documents or a billion numeric data points), provide visualization of numeric data, categorical data, genome sequences, chemical structures, and text documents - all in the same visual framework. By integrating these analyses, the Company's technology helps users rapidly move from data to knowledge, uncovering and advancing promising discoveries more quickly.

For further information, please visit

Battelle is the world's largest non-profit independent research and development organization, with 20,000 employees in more than 120 locations worldwide, including five national laboratories Battelle manages or co-manages for the U.S. Department of Energy. Headquartered in Columbus, Ohio, Battelle conducts $3.8 billion in R&D annually through contract research, laboratory management, and technology commercialization. Battelle provides innovative solutions to some of the world's most important problems including global climate change, sustainable energy technologies, high performance materials, next generation healthcare diagnostics and therapeutics, and advanced security solutions for people, infrastructure, and the nation. Battelle has a long history of developing successful commercial products in collaboration with its clients, ranging from products to fight diabetes, cancer, and heart disease to the development of the office copier machine (Xerox). As a non-profit charitable trust with an eye toward the future, Battelle actively supports and promotes science and math education.

For further information, please visit

Contact Information